NSF

Dear Research Advocate, On Capitol Hill : Senate Republicans have a new legislative proposal for COVID-19 emergency supplemental spending which includes provisions such as extended unemployment benefits and emergency funding for USPS, but no supplemental funding to restore COVID-19-eroded research dollars. Speaking up now is essential if there is to be an emergency spending bill that fully fights back COVID-19’s attack on the nation’s economy and health security. Reach out to your members of Congress to encourage them to include at least $26 billion in funding to restart lifesaving research supported by our health and science agencies. Here are two ways you can act right away: send this...

Dear Research Advocate, You may have paused yesterday in solidarity with the young scientists who galvanized the #ShutDownSTEM movement to listen and reflect on your personal and your organization’s role in ending racism; I did. The very first research project I was involved in worked hard to recruit its study volunteers from a diverse community; we were only modestly successful. That was more than 40 years ago; ensuring diversity in clinical trials is still a major obstacle. Overcoming health disparities is a related challenge, one that calls for — no, demands — far greater attention. Witness COVID-19. We may not know all the factors that are causing dramatically disproportionate harm to...

Dear Research Advocate, Almost three months into the 2020 fiscal year, Congress has finally passed a legislative package to fund the federal government. As of press time, the Senate is expected to finish clearing the package tonight. The White House has indicated that the President will sign, thus avoiding a shutdown at midnight on Friday. There are many positive developments for the medical and science research advocacy community in these bills, including: A significant funding increase of $2.6 billion for NIH, paving the way for faster medical progress and more lifesaving, job-producing R&D. An increase of $636 million for the CDC, including new resources to strengthen the agency’s 24...

Dear Research Advocate: As you know, there has been a cease fire in the shutdown and people are back to work, at least for now. Over the next two weeks, members of Congress will attempt to resolve the stalemate over funding for the President’s border wall, packaging it with the seven remaining FY 2019 spending bills, which include funding for the Food and Drug Administration (FDA) and the National Science Foundation (NSF). I am feeling optimistic about a deal being struck, not least because Sen. Richard Shelby (R-AL), Chairman of the Senate Appropriations Committee, and Representative Nita Lowey (D-NY), Chairwoman of the House Appropriations Committee, are leading the congressional...